Targeting CSF-1 ameliorates experimental autoimmune encephalomyelitis by depleting inflammatory monocytes and microglia in the central nervous system without affecting quiescent microglia.

Added 34 days ago (24.10.2020)
Authors: Hwang, D., Ishiwaka, L. L. W., Boehm, A., Sahin, Z., Casella, G., Jang, S., Seyedsadr, M., Gonzalez, M. V., Garifallou, J. P., Hakonarson, H., Zhang, G.-X., Rostami, A., Ciric, B.
Source: bioRxiv
Read article